Skip to main content

Table 2 Subject Characteristics Prior to Treatment

From: Effect of optically modified polyethylene terephthalate fiber socks on chronic foot pain

  Demographics McGill
All Subjects Age % male I-a I-b I-a+b II III
Celliant™ 57.7 ± 11.8 70% 1.2 ± 0.8 0.6 ± 0.7 1.9 ± 1.5 4.7 ± 2.4 2.6 ± 1.0
Control 61.6 ± 11.8 68% 1.3 ± 0.7 1.1 ± 1.0 2.4 ± 1.6 5.4 ± 2.8 3.1 ± 1.1
DPN group        
Celliant™ 63.0 ± 7.7 85% 1.2 ± 0.9 0.6 ± 0.7 1.9 ± 1.5 5.1 ± 2.6 2.7 ± 1.1
Control 63.9 ± 11.0 77% 1.4 ± 0.7 1.2 ± 1.1 2.5 ± 1.7 5.2 ± 2.9 2.9 ± 0.9
Non-DPN group        
Celliant™ 52.7 ± 13.1 57% 1.2 ± 0.8 0.6 ± 0.8 1.9 ± 1.5 4.4 ± 2.3 2.4 ± 0.9
Control 59.5 ± 12.3 60% 1.3 ± 0.8 1.1 ± 1.0 2.3 ± 1.6 5.6 ± 2.8 3.3 ± 1.2
  Brief Pain Inventory     
All Subjects Pain Severity Pain Interference VAS SF-36: Bodily Pain
Celliant™ 4.2 ± 2.4   5.8 ± 2.4 37.8 ± 8.1   4.2 ± 2.4  
Control 5.5 ± 2.6   6.4 ± 1.8 34.6 ± 7.8   5.5 ± 2.6  
DPN group        
Celliant™ 4.9 ± 2.0   4.7 ± 2.5 5.9 ± 2.4   34.2 ± 7.4  
Control 5.1 ± 2.3   5.5 ± 2.9 6.1 ± 1.9   36.1 ± 7.5  
Non-DPN group        
Celliant™ 3.9 ± 1.9*   3.8 ± 2.3* 5.8 ± 2.5   40.8 ± 7.7  
Control 5.3 ± 1.6*   5.6 ± 2.3* 6.6 ± 1.8   33.3 ± 8.1  
  1. *denotes significant (p < 0.05) differences between Celliant™ and Control subjects.
\